Obstet Gynecol Sci.  2020 Apr;63(3):278-285. 10.5468/ogs.2020.63.3.278.

Efficacy of fetal cardiac axis evaluation in the first trimester as a screening tool for congenital heart defect or aneuploidy

• Jung YJ
• Lee BR
• Kim GJ

• KMID: 2500417
• DOI: http://doi.org/10.5468/ogs.2020.63.3.278

Abstract

Objective
To prove the efficacy of determining the abnormal fetal cardiac axis for screening congenital heart defects (CHDs) and predicting fetal aneuploidy at 11.0 to 13.6 weeks of pregnancy.
Methods
This retrospective study was performed at a single high-risk pregnancy center. The fetal cardiac axis was evaluated between 11.0 and 13.6 weeks of gestation in 142 fetuses. The cardiac axis in a 4-chamber view was measured as the angle between the line tracing the long axis of the heart and the line bisecting the thorax in the anteroposterior direction. A CHD was confirmed based on the second- to third-trimester fetal status or postnatal imaging. Aneuploidy was diagnosed using chorionic villus sampling, amniocentesis, or genetic testing after birth. Fisher’s exact test was performed to assess the association between the fetal cardiac axis and the abnormal fetal status. A 2-way contingence table analysis was performed to confirm the efficacy of the fetal cardiac axis as a screening tool.
Results
Among the 142 fetuses, 10 had a CHD while 17 had aneuploidy. The abnormal fetal cardiac axis was significantly associated with CHDs (P=0.013) and aneuploidy (P=0.010). None of the fetuses with CHDs or aneuploidy had an isolated abnormal cardiac axis alone without other sonographic findings. The sensitivity of the fetal cardiac axis was 50.0% for CHDs and 41.2% for aneuploidy.
Conclusion
The fetal cardiac axis can be an additional helpful tool for prenatal screening of CHDs and aneuploidy in the first trimester.

Keyword

Fetal heart; Axis; Congenital heart defect; Aneuploidy; First trimester

Figure

• 

  Fig. 1 A schematic diagram of the cardiac axis measurement.a, the line bisecting the thorax in the anteroposterior direction; b, the line tracing the long axis of the heart; L, left aspect of the fetus; R, right aspect of the fetus; P, posterior aspect of the fetus.

• 

  Fig. 2 Normal and abnormal fetal cardiac axes of fetuses in the first trimester observed using ultrasonography. Dotted lines are the lines bisecting the thorax in the anteroposterior direction. Full lines are the lines tracing the long axis of the heart. (A) Normal: 65.3° at 11.0 weeks. The fetus was delivered through a cesarean section at 39.0 weeks of gestation. (B) Left deviation: 75.4° at 12.4 weeks. Atrioventricular septal defect observed using fetal echocardiography. Trisomy 13: Fetal death in utero was diagnosed at 14.5 weeks of gestation. (C) Right deviation: 10.1° at 12.2 weeks. Ventricular septal defect, aortic stenosis, mitral atresia, and left ventricular hypoplasia observed using fetal echocardiography. Fetal death in utero was diagnosed 13.4 weeks of gestation.L, left aspect of fetus; R, right aspect of fetus; P, posterior aspect of fetus.

Reference

1. Heron M. Deaths: leading causes for 2014. Natl Vital Stat Report. 2016; 65:1–96.

2. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014; 129:2183–2242. PMID: 24763516.

3. Souka AP, Pilalis A, Kavalakis Y, Kosmas Y, Antsaklis P, Antsaklis A. Assessment of fetal anatomy at the 11–14-week ultrasound examination. Ultrasound Obstet Gynecol. 2004; 24:730–734. PMID: 15586371.

4. Rasiah SV, Publicover M, Ewer AK, Khan KS, Kilby MD, Zamora J. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol. 2006; 28:110–116. PMID: 16795132.

5. Kim GJ. Why we do the 1st trimester echocardiography. Ultrasound Med Biol. 2017; 43:S135.

6. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ. 1999; 318:81–85. PMID: 9880278.

7. Schwärzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10–14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol. 1999; 106:1029–1034. PMID: 10519427.

8. Timmerman E, Clur SA, Pajkrt E, Bilardo CM. First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects. Ultrasound Obstet Gynecol. 2010; 36:668–675. PMID: 20617506.

9. Borrell A, Grande M, Bennasar M, Borobio V, Jimenez JM, Stergiotou I, et al. First-trimester detection of major cardiac defects with the use of ductus venosus blood flow. Ultrasound Obstet Gynecol. 2013; 42:51–57. PMID: 23152003.

10. Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol. 2011; 117:1384–1391. PMID: 21606749.

11. Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther. 2011; 29:127–134. PMID: 21160164.

12. Sinkovskaya ES, Chaoui R, Karl K, Andreeva E, Zhuchenko L, Abuhamad AZ. Fetal cardiac axis and congenital heart defects in early gestation. Obstet Gynecol. 2015; 125:453–460. PMID: 25568997.

13. Crawford DC, Chita SK, Allan LD. Prenatal detection of congenital heart disease: factors affecting obstetric management and survival. Am J Obstet Gynecol. 1988; 159:352–356. PMID: 3407692.

14. Copel JA, Pilu G, Kleinman CS. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol. 1986; 154:1121–1132. PMID: 2939723.

15. Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 1995; 5:15–19. PMID: 7850583.

16. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol. 1998; 12:380–384. PMID: 9918085.

17. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol. 2006; 27:151–155. PMID: 16388509.

18. Choi SJ. Clinical implications of nuchal translucency. Korean J Obstet Gynecol. 2010; 53:1–14.

19. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992; 304:867–869. PMID: 1392745.

20. Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH. Absent nasal bone at 11–14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol. 2003; 22:31–35. PMID: 12858299.

21. Fregin GF. Medical evaluation of the cardiovascular system. Vet Clin North Am Equine Pract. 1992; 8:329–346. PMID: 1643546.

22. Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007; 115:3015–3038. PMID: 17519398.

23. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004; 191:1446–1451. PMID: 15507981.

24. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, et al. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol. 2005; 106:288–294. PMID: 16055577.

25. DeVore GR. First-trimester fetal echocardiography: is the future now? Ultrasound Obstet Gynecol. 2002; 20:6–8. PMID: 12100410.

26. Yagel S, Cohen SM, Messing B. First and early second trimester fetal heart screening. Curr Opin Obstet Gynecol. 2007; 19:183–190. PMID: 17353687.

27. McAuliffe FM, Fong KW, Toi A, Chitayat D, Keating S, Johnson JA. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study. Am J Obstet Gynecol. 2005; 193:1260–1265. PMID: 16157148.

28. Salomon LJ, Alfirevic Z, Bilardo CM, Chalouhi GE, Ghi T, Kagan KO, et al. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2013; 41:102–113. PMID: 23280739.

29. Haak MC, Twisk JW, Van Vugt JM. How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol. 2002; 20:9–13. PMID: 12100411.

30. Smrcek JM, Berg C, Geipel A, Fimmers R, Diedrich K, Gembruch U. Early fetal echocardiography: heart biometry and visualization of cardiac structures between 10 and 15 weeks' gestation. J Ultrasound Med. 2006; 25:173–182. PMID: 16439780.

31. Sinkovskaya E, Horton S, Berkley EM, Cooper JK, Indika S, Abuhamad A. Defining the fetal cardiac axis between 11 + 0 and 14 + 6 weeks of gestation: experience with 100 consecutive pregnancies. Ultrasound Obstet Gynecol. 2010; 36:676–681. PMID: 20814876.

32. McBrien A, Howley L, Yamamoto Y, Hutchinson D, Hirose A, Sekar P, et al. Changes in fetal cardiac axis between 8 and 15 weeks' gestation. Ultrasound Obstet Gynecol. 2013; 42:653–658. PMID: 24273201.